Analysts Cut Centrus Energy Price Target Amid Mixed Nuclear Sector Outlook

Centrus Energy (LEU) has been the subject of a downward revision in its analyst price target, with several firms adjusting their forecasts downward in early March 2026. The revised targets now range between $14.50 and $16.00 per share, down from previous estimates as high as $20.50. This shift marks a notable change in sentiment for a company that has historically been viewed as a key player in domestic uranium enrichment technology, particularly for defense applications. The adjustment follows a broader reassessment of near-term capital deployment and project timelines at Centrus, including delays in the deployment of its advanced centrifuge technology at its Piketon, Ohio facility. While the company continues to secure contracts with the U.S. Department of Energy—such as the recent $230 million agreement for low-enriched uranium (LEU) production—the pace of commercial scale-up has slowed, prompting analysts to temper expectations. Key metrics reflect the shift: Centrus reported fourth-quarter 2025 revenue of $48.3 million, up 18% year-over-year, but net losses widened to $15.6 million due to increased R&D and infrastructure costs. The company’s URR (Uranium Recovery Rate) process, central to its competitive edge, remains in pilot phase, with full commercialization still projected for late 2026. The GDXJ (VanEck Junior Gold Miners ETF), which includes exposure to uranium-related equities, saw a 2.3% dip in the week following the announcement, suggesting market sensitivity to the revised outlook. The change primarily affects small-cap energy and defense technology investors, particularly those focused on nuclear supply chain resilience. While Centrus maintains long-term strategic relevance—especially given its role in reducing U.S. reliance on foreign uranium enrichment—the near-term earnings trajectory remains uncertain. Analysts now emphasize the need for consistent capital discipline and faster regulatory approvals to justify earlier optimism.